Trial Profile
Comparison of neuromuscular blockade's monitoring and clinical assessment during cisatracurium paralysis in critically ill patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2016
Price :
$35
*
At a glance
- Drugs Cisatracurium besilate (Primary)
- Indications Muscle hypertonia
- Focus Therapeutic Use
- Acronyms MONITOR
- 27 Apr 2016 New trial record